Canada markets closed
  • S&P/TSX

    20,491.01
    +284.60 (+1.41%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • DOW

    32,654.59
    +431.17 (+1.34%)
     
  • CAD/USD

    0.7806
    +0.0021 (+0.27%)
     
  • CRUDE OIL

    113.66
    -0.54 (-0.47%)
     
  • BTC-CAD

    38,672.04
    -65.07 (-0.17%)
     
  • CMC Crypto 200

    677.94
    +435.26 (+179.36%)
     
  • GOLD FUTURES

    1,813.60
    -0.40 (-0.02%)
     
  • RUSSELL 2000

    1,840.30
    +56.87 (+3.19%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • NASDAQ futures

    12,573.75
    +329.00 (+2.69%)
     
  • VOLATILITY

    26.10
    -1.37 (-4.99%)
     
  • FTSE

    7,518.35
    +53.55 (+0.72%)
     
  • NIKKEI 225

    26,659.75
    +112.70 (+0.42%)
     
  • CAD/EUR

    0.7396
    -0.0058 (-0.78%)
     

Stocks in play: Trulieve Cannabis Corp

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Today announced the opening of a new Trulieve-branded medical marijuana dispensary through its affiliate, Chamounix Ventures, LLC. The dispensary at 1222 Arch St. is in the Center City section of Philadelphia. This location becomes the Company's 160th owned, operated or affiliated dispensary nationwide. Trulieve Cannabis Corp shares C.TRUL are trading up $0.81 at $31.58.

Read:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting